Leukocyte immunoglobulin-like receptors: Novel innate receptors for human basophil activation and inhibition

Blood

Volumn 104, Issue 9, 2004, Pages 2832-2839

  Sloane, David E ^b   Tedla, Nicodemus ^b   Awoniyi, Muyiwa ^b   MacGlashan Jr , Donald W ^b   Borges, Luis ^b   Austen, K Frank ^b   Arm, Jonathan P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR GAMMA; HISTAMINE; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 4; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 3; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 7; MONOCLONAL ANTIBODY; PEPTIDOLEUKOTRIENE; TYROSINE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; BASOPHIL; CELL ACTIVATION; CELL SURFACE; CONCENTRATION RESPONSE; CONTACT ALLERGY; CONTROLLED STUDY; CROSS LINKING; GENE EXPRESSION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN MOTIF; RECEPTOR AFFINITY;

EID: 7244227848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0268     Document Type: Article

References (66)

1. Gurish MF, Tao H, Abonia JP, et al. Intestinal mast cell progenitors require CD49dβ7 (α4β7 integrin) for tissue-specific homing. J Exp Med. 2001;194: 1243-1252.
2. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328:257-265.
3. Denburg JA. Basophil and mast cell lineages in vitro and in vivo. Blood. 1992;79:846-860.
4. Denburg JA, Telizyn S, Messner H, et al. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophileosinophil progenitor. Blood. 1985;66:312-318.
5. Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J Exp Med. 1995;182:49-57.
6. Juhlin L, Michaelsson G. A new syndrome characterised by absence of eosinophils and basophils. Lancet. 1977;1:1233-1235.
7. Kasugai T, Okada M, Morimoto M, et al. Infection of Nippostrongylus brasiliensis induces normal increase of basophils in mast cell-deficient Ws/Ws rats with a small deletion at the kinase domain of c-kit. Blood. 1993;81:2521-2529.
8. Schroeder JT. Regulation of the production and activation of basophils. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Dermatology in General Medicine. New York: McGraw-Hill; 2003:324-329.
9. Galli SJ. Mast cells and basophils. Curr Opin Hematol. 2000;7:32-39.
10. Gauchat JF, Henchoz S, Mazzei G, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 1993;365:340-343.
11. MacGlashan DJ, White JM, Huang SK, et al. Secretion of IL-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol. 1994; 152:3006-3016.
12. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med. 1993;177: 605-611.
13. Kepley CL, McFeeley PJ, Oliver JM, Lipscomb MF. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med. 2001;164:1053-1058.
14. Nouri-Aria KT, Irani A-M, Jacobson MR, et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol. 2001;108:205-211.
15. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985;313:65-70.
16. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988;81:580-589.
17. Dvorak AM, Mihm MC Jr, Dvorak HF. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol. 1976; 116:687-695.
18. Dvorak HF, Mihm MC Jr. Basophilic leukocytes in allergic contact dermatitis. J Exp Med. 1972;135: 235-254.
19. Dvorak HF, Mihm MC Jr. Basophilic leukocytes in a case of poison ivy. N Engl J Med. 1971;285:54-55.
20. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 1997;159:5192-5196.
21. Cosman D, Fanger N, Borges L, et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 1997; 7:273-282.
22. Cella M, Dohring C, Samaridis J, et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med. 1997;185: 1743-1751.
23. Colonna M, Navarro F, Bellón T, et al. A common inhibitory receptor for major histocompatibitity complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186: 1809-1818.
24. Samaridis J, Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol. 1997;27:660-665.
25. Banham AH, Colonna M, Cella M, et al. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily. J Leukocyte Biol. 1999;65:841-845.
26. Wilson MJ, Torkar M, Haude A, et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA. 2000;97:4778-4783.
27. Liu RW, Kim J, Nwankwo C, Ashworth LK, Arm JP. Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4. Immunogenetics. 2000;51:659-669.
28. Trowsdale J, Barten R, Haude A, et al. The genomic context of natural killer receptor extended gene families. Immunol Rev. 2001;181: 20-38.
29. Saverino D, Fabbi M, Ghiotto F, et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol. 2000;165:3742-3755.
30. Nakajima H, Samaridis J, Angman L, Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J Immunol. 1999;162:5-8.
31. Tedla N, Gibson K, McNeil HP, et al. The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium. Am J Pathol. 2002;160:425-431.
32. Riske F, Hakimi J, Mallamaci M, et al. High affinity human IgE receptor (FcεRI): analysis of functional domains of the alpha-subunit with monoclonal antibodies. J Biol Chem. 1991;266:11245-11251.
33. Tedla N, Bandeira-Melo C, Tassinari P, et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc Natl Acad Sci USA. 2003;3:1174-1179.
34. 4 export from human polymorphonuclear leukocytes. J Biol Chem. 1990;265:13438-13441.
35. Sanchez Meija RO, Lam BK, Arm JP. Matrix-associated TGF-β1 primes mouse bone marrow-derived mast cells for increased FcεRI-dependent eicosanoid biosynthesis. Am J Respir Cell Mol Biol. 2000;22:557-565.
36. Okayama Y, Hagaman DD, Metcalfe DD. A comparison of mediators released or generated by IFNγ-treated human mast cells following aggregation of FcγRI or FcεRI. J Immunol. 2001;166: 4705-4712.
37. Colonna M, Nakajima H, Cella M. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin Immunol. 2000;12:121-127.
38. Ochensberger B, Tassera L, Bifrare D, Rihs S, Dahinden CA. Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists. Eur J Immunol. 1999;29:11-22.
39. Cella M, Jarrossay D, Facchetti F, et al. Plasma-cytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;6:919-923.
40. MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol. 1986;136:2231-2239.
41. Miura K, Saini SS, Gauvreau G, MacGlashan DWJ. Differences in functional consequences and signal transduction induced by IL-3, IL-5, and nerve growth factor in human basophils. J Immunol. 2001;167:2282-2291.
42. Burgi B, Otten UH, Ochensberger B, et al. Basophil priming by neurotrophic factors: activation through the trk receptor. J Immunol. 1996;157: 5582-5588.
43. Ochensberger B, Rihs S, Brunner T, Dahinden CA. IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. Blood. 1995; 86:4039-4049.
44. 4 in response to soluble agonists. J Immunol. 1991;147:3855-3861.
45. Weber M, Uguccioni M, Ochensberger B, et al. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol. 1995;154:4166-4172.
46. MacDonald SM, Lichtenstein LM, Proud D, et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987; 139:506-512,
47. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science. 1995;269:688-690.
48. Schroeder JT, Lichtenstein LM, MacDonald SM, An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils. J Exp Med. 1996;183:1265-1270.
49. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax. 1999;54:268-272.
50. Bleharski JR, Li H, Meinken C, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527-1530.
51. Bischoff SC, Dahinden CA. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med. 1992;175:237-244.
52. Alam R, Lett-Brown MA, Forsythe PA, et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest. 1992;89:723-728.
53. Dahinden CA, Kurimoto J, Baggiolini M, Dewald B, Walz A. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF. Int Arch Allergy Appl Immunol. 1989;90:113-118.
54. Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils: a comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine. J Immunol. 1990;145: 1897-1905.
55. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science. 2000;290:84-89.
56. Kubagawa H, Chen CC, Le Hong H, et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med. 1999;189:309-318.
57. Yokoyama WM. What goes up must come down: the emerging spectrum of inhibitory receptors. J Exp Med. 1997;186:1803-1808.
58. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275-290.
59. Muhlfeld AS, Segerer S, Hudkins K, et al. Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol. 2003;163:1127-1136.
60. Nakamura A, Yuasa T, Ujike A, et al. Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med. 2000;191:899-906.
61. Ujike A, Ishikawa Y, Ono M, et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med. 1999;189:1573-1579.
62. Kepley CL, Cambier JC, Morel PA, et al. Negative regulation of FcepsilonRI signaling by Fcgamma-RII costimulation in human blood basophils. J Allergy Clin Immunol. 2000;106:337-348.
63. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degradation. Nat Med. 2002;8: 518-521.
64. Daheshia M, Friend DS, Grusby MJ, Austen KF, Katz HR. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J Exp Med. 2001;194:227-234.
65. Feldweg AM, Friend DS, Zhou JS, et al. gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo. Eur J Immunol. 2003;33:2262-2268.
66. Zhou JS, Friend DS, Feldweg AM, et al. Prevention of lipopolysaccharide- induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils. J Exp Med. 2003;198:1243-1251.